Animal Genetics Market

The global animal genetics market was valued at USD 6.64 billion in 2026 and is projected to reach USD 9.37 billion by 2031, growing at a CAGR of 7.1% during the forecast period.

Rising global consumption of high-quality animal-derived protein and dairy products is prompting producers to select breeding stock with stronger production traits, lifting demand for genetics services across poultry, swine, and dairy operations. Livestock owners are placing greater emphasis on animal health, productivity, and breeding efficiency to reduce input costs while raising output per animal. Genetics providers are increasingly positioning services around disease prevention, screening populations for hereditary conditions before they affect a herd. This has accelerated adoption of molecular and genomic tools within livestock improvement programs.

To know about the assumptions considered for the study download the pdf brochure

Genetics companies are pairing genomic selection with advanced phenotyping technologies, combining on-farm trait data with genomic estimated breeding values to sharpen selection accuracy. This integration is reinforced by rising R&D investment, as breeding organizations expand nucleus herds, sequencing capacity, and data infrastructure to shorten generation intervals. Digital tools for herd data collection are lowering the barrier to adopting genetics services in regions with historically limited technical capacity.

The prominent players in the animal genetics market are Hendrix Genetics BV (Netherlands), Topigs Norsvin (Netherlands), Genus plc (UK), CRV (Netherlands), and URUS Group LP, among others. These companies pursue a mix of organic and inorganic growth strategies, including new genetic line launches, R&D investment, and proprietary trait development, alongside mergers, joint ventures, and collaborations with genotyping and technology partners. These initiatives are aimed at strengthening genetic gain and expanding reach into underpenetrated markets.

• In January 2025, Hendrix Genetics BV (Netherlands) closed the merger of its swine genetics division, Hypor, with Danish Genetics, combining both organizations' breeding programs under one entity.
• In 2025, Topigs Norsvin (Netherlands) raised its research and innovation budget to USD 41.85 million, up about 9% from 2024, while deepening integration partnerships with large-scale pork producers in China, Spain, and the US.
• In April 2025, Genus plc (UK) secured US Food and Drug Administration approval for its PRRS-resistant pig gene edit, clearing the trait for commercial use in the US food supply chain.
• In 2024, CRV (Netherlands) partnered with VikingGenetics to exchange Holstein breeding candidate genotypes and pursue joint work on methane-related breeding traits.

Hendrix Genetics BV (Netherlands)

Hendrix Genetics BV (Netherlands) is a leading multi-species animal breeding company focused on improving the genetic potential of livestock and aquaculture species through advanced breeding programs, genomic technologies, and precision selection. The company operates across layers, turkeys, swine, salmon, trout, shrimp, and traditional poultry, with a portfolio of globally recognized breeding brands including ISA, Bovans, DeKalb, Hybrid, Hypor, and Landcatch. In the animal genetics market, Hendrix Genetics leverages genomic selection, performance testing, reproductive technologies, and data-driven breeding to develop animals with enhanced productivity, feed efficiency, disease resilience, fertility, and sustainability. The company continuously invests in R&D, digital breeding platforms, and strategic collaborations to accelerate genetic progress while supporting sustainable animal protein production. Hendrix Genetics maintains a strong global presence through breeding centers, multiplication networks, and commercial operations across Europe, North America, Latin America, Asia Pacific, the Middle East, and Africa.

Topigs Norsvin (Netherlands)

Topigs Norsvin (Netherlands) is a global leader in swine genetics specializing in the development of high-performance breeding pigs for commercial pork production. Formed through the integration of Dutch and Norwegian breeding expertise, the company combines extensive genomic research, advanced data analytics, and large-scale performance testing to deliver genetically superior sire and dam lines. Its portfolio includes maternal and terminal breeding lines designed to improve feed conversion efficiency, growth rate, carcass quality, fertility, robustness, and disease resilience. Topigs Norsvin applies genomic selection, reproductive technologies, and continuous genetic evaluation to accelerate breeding progress while supporting sustainable and efficient pork production. The company collaborates closely with producers, research institutions, and distribution partners worldwide. It has established a strong presence across Europe, North America, Latin America, Asia Pacific, and other key pork-producing regions.

Market Ranking

In 2025, the animal genetics market was competitive, with Hendrix Genetics BV (Netherlands), Genus plc (UK), CRV (Netherlands), Topigs Norsvin (Netherlands), and URUS Group LP (US) collectively accounting for approximately 58–60% of the market. As livestock producers increasingly prioritized productivity, disease resistance, sustainability, and genetic gain, market participants accelerated investments in genomic selection, whole-genome sequencing, reproductive technologies, gene editing, artificial intelligence (AI)-enabled breeding, and precision livestock breeding platforms.

• Hendrix Genetics BV led the market through its diversified multi-species breeding portfolio spanning poultry, swine, and aquaculture. The company differentiated itself through long-term breeding programs, extensive genomic selection capabilities, and globally recognized brands such as ISA, Bovans, DeKalb, Hybrid, Hypor, and Landcatch, enabling broad exposure across multiple animal protein sectors.
• Topigs Norsvin strengthened its leadership in swine genetics through its farmer-owned cooperative structure and one of the largest genomic reference populations. The company combines advanced genomic selection, performance testing, and reproductive technologies to develop breeding lines with superior feed efficiency, fertility, robustness, carcass quality, and disease resilience for commercial pork producers worldwide.
• Genus plc maintained a strong competitive position through its ABS Global and PIC businesses, offering industry-leading cattle and swine genetics. The company continued to differentiate itself through genomic breeding, sexed semen technologies, digital herd management solutions, and gene-editing innovations, including PRRS-resistant pig genetics, while serving customers in more than 80 countries.
• CRV strengthened its position through cooperative ownership and a strong focus on dairy and beef cattle genetics. Its breeding strategy combines extensive on-farm performance data, genomic evaluations, fertility and health indexes, and sustainability-focused breeding programs, supported by collaborations with international breeding organizations to improve genetic progress globally.
• URUS Group LP has built a strong position in the animal genetics market through its integrated network of dairy and beef genetics companies, including Alta Genetics, GENEX, PEAK, SCCL, and VAS. The company combines elite germplasm, genomic evaluation, artificial insemination, embryo technologies, and precision herd management solutions to accelerate genetic gain, improve reproductive performance, and enhance milk and beef efficiency for livestock producers worldwide.

Across the competitive landscape, companies are increasingly focused on genomic selection, AI-driven breeding decisions, reproductive technologies, gene editing, precision phenotyping, and digital breeding platforms to differentiate through faster genetic gain, improved animal health, feed efficiency, fertility, and sustainability. These developments reflect the continued evolution of the animal genetics market as breeding organizations invest in advanced genomic technologies to meet the growing global demand for efficient, resilient, and sustainable animal protein production.

Related Reports:

Animal Genetics Market by Live Animal (Bovine, Porcine, Canine), Products & Services (Genetic Materials (Semen, Embryo), Genetic Testing Services (Disease Tests, Trait Tests), Technology (PCR, NGS, rDNA), End User (Animal Farm) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]